Pharma

HIPAA Guidelines: Understanding HIPAA Compliance on the Cloud

Health Insurance Portability and Accountability Act (HIPAA) mandates industry-wide standards for protection and confidential handling of the electronic healthcare information for electronic billing and other processes. In order to maintain the HIPAA Privacy regulations, the Healthcare providers and organizations must develop and follow certain procedures to ensure the confidentiality and security of the Protected Health Information(PHI). The ‘Guidance on HIPAA and Cloud Computing’ released in 2016, by the US Government of Health and Human Services(HSS) provides information on maintaining HIPAA compliance while using cloud computing services for storing and managing ePHI. Based on this, the HealthCare organization and Cloud Service Provider(CSP) is directly liable for meeting both the business associate agreement(BSS) and compliance with the associated requirements of the HIPAA rules.

Data Analytics and Data Science for LifeSciences in the Cloud

Problem statement for the industry

Pharma companies are pursuing the ultimate moonshot goal of changing the way medicines are developed so the right treatment can be delivered to the right patient at the right time. Thus, enabling the delivery of highly personalized healthcare, which effects the Pharma, Life Science and Healthcare verticals.

Secure & Compliant Infrastructure On-demand for Pharma & Life Sciences in the Cloud

Secure and compliant Infrastructure is one of the fundamental requirements for Pharma and life Sciences companies in the cloud. These industries require scalable compute and storage capabilities to run advanced algorithms and processes to tabulate drug and reagent performance, to increase the overall drug efficacy. The Infrastructure must be GxP and HITRUST certified to ensure developed drugs can pass regulatory approvals. This is required for the delivery of highly personalized healthcare, improving the quality of evidence collected from Real-World Data and enhancing the Pharmacovigilance (Drug Safety) aspect of drug development and research.

Cloud Healthcare Security

Not Getting the ROI You Expected from the Cloud? Look at Your Operating Model

According to a recent Accenture analysis, two out of three life sciences organizations struggle to achieve optimal return from their investments in cloud computing. This is unfortunate, considering that the cloud is clearly emerging as a game changer in pharma, biotech, medtech and other companies in this space. In pharma alone, the cloud computing market is expected to reach $12.1 billion in 2022, up from $4.7 billion in 2017.

Scroll to Top